eXoZymes selects Curia to scale up its NCT manufacturing process
eXoZymes ($EXOZ) entered an agreement with contract manufacturer Curia to transfer and scale its NCT production process. Work will take place at Curia facilities in Spain and Italy, covering enzyme production, the cell-free reaction and product purification. The program follows pilot-scale validation and is intended to establish a pathway toward larger-scale manufacturing in 2027. The partners will also conduct process modeling and engineering analysis to assess the next production scale. Manage
0